Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Faculty of Chemistry and Pharmacy, Sofia University, Sofia 1164, Bulgaria.
J Phys Chem B. 2023 Jun 29;127(25):5588-5600. doi: 10.1021/acs.jpcb.3c01637. Epub 2023 Jun 16.
Strontium (Sr), an alkali metal with properties similar to calcium, in the form of soluble salts is used to treat osteoporosis. Despite the information accumulated on the role of Sr as a Ca mimetic in biology and medicine, there is no systematic study of how the outcome of the competition between the two dications depends on the physicochemical properties of (i) the metal ions, (ii) the first- and second-shell ligands, and (iii) the protein matrix. Specifically, the key features of a Ca-binding protein that enable Sr to displace Ca remain unclear. To address this, we studied the competition between Ca and Sr in protein Ca-binding sites using density functional theory combined with the polarizable continuum model. Our findings indicate that Ca-sites with multiple strong charge-donating protein ligands, including one or more bidentately bound Asp/Glu that are relatively buried and rigid are protected against Sr attack. On the other hand, Ca-sites crowded with multiple protein ligands may be prone to Sr displacement if they are solvent-exposed and flexible enough so that an extra backbone ligand from the outer shell can bind to Sr. In addition, solvent-exposed Ca sites with only a few weak charge-donating ligands that can rearrange to fit the strontium's coordination requirements are susceptible to Sr displacement. We provide the physical basis of these results and discuss potential novel protein targets of therapeutic Sr.
锶(Sr)是一种碱金属,其性质与钙相似,以可溶性盐的形式用于治疗骨质疏松症。尽管已经积累了大量关于 Sr 作为 Ca 类似物在生物学和医学中的作用的信息,但对于这两种二价阳离子之间的竞争结果如何取决于(i)金属离子、(ii)第一和第二配位层配体以及(iii)蛋白质基质的物理化学性质,还没有系统的研究。具体来说,使 Sr 能够取代 Ca 的 Ca 结合蛋白的关键特征仍不清楚。为了解决这个问题,我们使用密度泛函理论结合极化连续体模型研究了蛋白质 Ca 结合位点中 Ca 和 Sr 之间的竞争。我们的研究结果表明,具有多个强电荷供体蛋白配体的 Ca 位点,包括一个或多个相对埋藏且刚性的双齿结合的 Asp/Glu,可免受 Sr 攻击。另一方面,如果拥挤有多个蛋白配体的 Ca 位点具有足够的溶剂暴露性和灵活性,使得外壳的额外骨架配体可以与 Sr 结合,则它们可能容易被 Sr 取代。此外,暴露于溶剂的 Ca 位点只有少数可以重新排列以适应锶配位要求的弱电荷供体配体,容易被 Sr 取代。我们提供了这些结果的物理基础,并讨论了治疗用 Sr 的潜在新型蛋白质靶标。